STI Screening: What the Guidelines Actually Recommend for Women, and When

The core of STI screening guidance for women is short and concrete: per the CDC's STI Treatment Guidelines (2021), all sexually active women under 25 should be tested for chlamydia and gonorrhea every year; everyone between 13 and 64 should be tested for HIV at least once, per the CDC's 2006 recommendation affirmed by the USPSTF in 2019; all pregnant women are tested for syphilis, HIV, and hepatitis B early in pregnancy; and women 25 and older continue chlamydia and gonorrhea screening only when risk factors are present. Most of these infections cause no symptoms — that is precisely why screening, not symptom-spotting, is the strategy.

This article explains which tests are recommended at which ages, how screening works in practice, and what the guidelines deliberately do not recommend, including routine herpes testing without symptoms. It publishes information, not medical advice — your specific screening needs depend on your history and should be decided with your own clinician.

Why screen under 25 for chlamydia and gonorrhea?

Because that is where the infections concentrate, and where they do their quietest damage. Chlamydia remains the most commonly reported notifiable condition in the United States — about 1.6 million cases reported in 2023, per the CDC's national surveillance report — with highest rates among women in their early twenties. Untreated chlamydia and gonorrhea can ascend silently to the uterus and fallopian tubes, causing pelvic inflammatory disease, a term for infection of the upper reproductive tract that can lead to chronic pelvic pain, ectopic pregnancy, and infertility. Annual screening catches infections while a short course of antibiotics resolves them, and per USPSTF reviews, screening programs in this age group reduce pelvic inflammatory disease incidence.

What happens after age 25?

Screening does not stop — it becomes risk-based. Per the CDC's 2021 guidelines, women 25 and older should be tested for chlamydia and gonorrhea if risk factors are present: a new sex partner, more than one partner, a partner with concurrent partners, or a partner with an STI. A practical reading of that: a new relationship is a reason to test, and periodic testing in non-monogamous situations is the guideline's clear intent. The 25 cutoff is a population threshold, not a statement that infection becomes impossible — gonorrhea and syphilis rates in the US have been climbing in recent years across age groups, per CDC surveillance.

How does HIV testing fit in?

Once in a lifetime is the floor. Per the CDC's 2006 recommendation and the USPSTF's 2019 grade A statement, everyone ages 13 to 64 should be screened for HIV at least once, with repeat testing at least annually for people with ongoing risk factors — new or multiple partners, a partner with HIV, or injection drug use. Modern fourth-generation laboratory tests detect HIV infection within a few weeks of exposure, and a positive result today connects to effective treatment: per the START trial published in the New England Journal of Medicine (2015), early antiretroviral treatment reduces serious illness and death, and people with sustained undetectable viral loads do not transmit HIV sexually, per extensive partner-study evidence reviewed by the NIH.

What about syphilis and pregnancy?

Syphilis screening in pregnancy is universal and early — the first prenatal visit for all, with repeat testing in the third trimester and at delivery for women at risk, per the CDC's 2021 guidelines. The urgency is concrete: congenital syphilis, passed during pregnancy or birth, can cause stillbirth and severe infant illness, and US cases have risen roughly tenfold in a decade — 3,761 cases reported in 2022, per the CDC's surveillance data, the highest count since the 1950s. Syphilis detected in the mother is treatable with penicillin during pregnancy, which is why the guideline treats every prenatal visit as a screening checkpoint.

Related stories: Breast Screening: What the Guidelines Actually Recommend, Age by Age · Genetic Testing for Breast Cancer Risk: Who Should Consider It, per the Guidelines.

Why is herpes screening not recommended?

This surprises many readers. Per the CDC's 2021 guidelines, blood tests for herpes simplex virus are not recommended for people without symptoms or a known exposure, for two reasons: roughly half of American adults carry HSV-1 and about one in eight have HSV-2, so a positive antibody test is common and hard to interpret, and available blood tests cannot predict when or whether genital outbreaks will occur. Testing is appropriate when sores are present — a swab of the sore is diagnostic — or after a specific exposure discussion with a clinician. Screening exists to change outcomes; herpes blood testing in asymptomatic people has not been shown to do that.

How is screening actually done?

Easier than most expect. Chlamydia and gonorrhea testing uses a urine sample or a vaginal swab — in many clinics you can self-collect the swab, and per studies reviewed by the CDC, self-collected vaginal swabs perform comparably to clinician-collected ones. HIV, syphilis, and hepatitis testing are blood draws; rapid HIV tests use a finger stick and return results in about 20 minutes. Screening is painless enough that the main barrier is scheduling, and confidentiality protections for STI services are explicit in federal and state law — this category of care has its own privacy rules precisely so the barrier stays low.

When to talk to a clinician

Seek care promptly for symptoms: abnormal discharge, burning with urination, pelvic pain, sores, or bleeding between periods — symptoms are evaluated, not merely screened. Make a screening plan if you are under 25 and sexually active without a current annual test; if you have a new partner and want both of you tested before unprotected sex, which many couples do together; if you are pregnant or planning pregnancy; or if a partner tells you they have been diagnosed with an STI — per CDC guidance, partner diagnosis is a reason for your own testing and possible preventive treatment. If an exposure was very recent, ask about timing: some infections take one to two weeks to become detectable, and HIV tests are repeated on a schedule after potential exposure.

Frequently asked questions

I feel completely healthy. Do I still need screening?

Yes — that is exactly who screening is for. Chlamydia in women is asymptomatic in most cases, per CDC estimates, and the consequences — pelvic inflammatory disease, infertility — arrive later without any warning episode. Feeling healthy while infected is the default presentation, which is why guidelines attach screening to age and risk rather than symptoms.

Does a Pap test check for STIs?

A Pap test looks for abnormal cervical cells; it is not an STI test. A HPV test, often done alongside it, checks for the virus that causes cervical cancer — which is cancer screening, not a test for the STIs discussed here. Chlamydia and gonorrhea can sometimes be added to the same visit's samples, so if you want STI screening, say so explicitly rather than assuming the routine visit covered it.

How soon after sex can I test?

It depends on the infection. Chlamydia and gonorrhea are typically detectable within one to two weeks of exposure; syphilis within about three to six weeks; HIV by modern lab tests within a few weeks, with a follow-up test per clinician guidance. If you test immediately after an exposure, a negative result means little — the reliable approach per CDC guidance is testing now and repeating at the appropriate window.

Is screening different for women who have sex with women?

The assumptions differ; the tests are the same. Per CDC guidance, women who have sex with women still need routine chlamydia and gonorrhea screening per age and risk, since transmission between partners occurs, and HIV testing guidance applies regardless of partner history. What changes is the conversation — telling your clinician accurately about your partners and practices is what makes any guideline table apply correctly to you.